All Stories

  1. Convergent Network Localization of Brain Stimulation Targets for Trait Anxiety
  2. Altered neurodevelopmental trajectories of brain structure in Tourette syndrome and Chronic Tic Disorders
  3. Developmental delay in attaining adult levels of motor excitability in children and adolescents with Tourette syndrome: a mega-analysis study
  4. Doxycycline, Schizophrenia, and Toxoplasmosis
  5. Tourette experts do care about complementary medicine . . .
  6. Talking to the doctor reduces tics more than trying not to tic
  7. Correlating clinical course with baseline subcortical shape in provisional tic disorder
  8. Diagnostic Criteria for Primary Tic Disorders: More Reappraisal
  9. Tourette syndrome research highlights from 2023
  10. What's new with tics and Tourette's? Highlights from 2023.
  11. Tics that started recently usually get better but almost never go away completely.
  12. Tics in ADHD
  13. Network Localization of Brain Stimulation Targets for Trait Anxiety
  14. Tourette syndrome research highlights from 2022
  15. Door-To-Door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  16. Smoke gets in your tics
  17. Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders
  18. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
  19. Early‐Life and Family Risk Factors for Tic Disorder Persistence into Adulthood
  20. Tics in ADHD
  21. Finding reviewer suggestions for multi-author papers
  22. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  23. Editorial: Recent advances in understanding Tourette syndrome, tic disorders and functional tics
  24. Smoke gets in your tics
  25. Will people buzz their wrist in their daily life to help their tics?
  26. Testing whether median nerve stimulation helps tics by the mechanism we thought it did
  27. Tics in ADHD
  28. Suggestions for new NIH grant applicants
  29. Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial
  30. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  31. TikTok Tourette’s: Are We Witnessing a Rise in Functional Tic-Like Behavior Driven by Adolescent Social Media Use?
  32. Tic prevalence by direct observation in an elementary school
  33. Tourette syndrome research highlights from 2021
  34. Diagnosis and Management of Functional Tic-Like Phenomena
  35. Door-to-door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  36. Why Tic Severity Changes from Then to Now and from Here to There
  37. 3.122 Open Trial of Median Nerve Stimulation for the Treatment of Tourette’s Disorder
  38. 13.2 Predictors of Tic Symptom Evolution After First Onset
  39. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  40. Median nerve stimulation for treatment of tics: A 4-week, open trial with ecological momentary assessment
  41. TikTok Tourette's: are we witnessing a rise in neurological conditions driven by adolescent social media use?
  42. Why tic severity changes from then to now and from here to there
  43. The start of the biggest brain imaging and genetics study ever in Tourette syndrome
  44. Finding reviewer suggestions for multi-author papers
  45. Optimal timing for lithium levels
  46. Tourette syndrome research highlights from 2021
  47. Tourette syndrome research highlights from 2020
  48. Neurobiology and Functional Anatomy of Tic Disorders
  49. The timing of tics is fractal, even in the first few months of a tic disorder
  50. Tourette syndrome research highlights from 2020
  51. Treatment failure in persistent tic disorders: an expert clinicians’ consensus-based definition
  52. Predicting Clinical Course from Subcortical Shape in Provisional Tic Disorder
  53. Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
  54. Recent progress on Tourette syndrome
  55. A Comprehensive Review of Tic Disorders in Children
  56. What happens to tic disorders over time?
  57. "I can hold my tics back for a while. What does that tell me?"
  58. TicTimer Web: software for measuring tic suppression remotely
  59. Electronic medical records need to accommodate confidentiality for presymptomatic testing
  60. The Child with Tics or Other Common Movement Disorders
  61. Tourette syndrome research highlights from 2019
  62. Course of tic disorders over the lifespan
  63. Tourette syndrome research highlights from 2019
  64. TicTimer Web: software for measuring tic suppression remotely
  65. Correlates and clinical implications of tic suppressibility
  66. Size of hippocampus predicts improvement in children with recent-onset tics
  67. Phonic tics and one motor tic? Call it Tourette syndrome.
  68. Can we measure Parkinson disease severity with levodopa and MRI?
  69. Age-dependent differences in functional brain networks are atypical in Tourette syndrome
  70. In obesity, pictures of high-calorie food elicit dopamine release equally when hungry or full.
  71. Hippocampal volume in Provisional Tic Disorder predicts tic severity at 12-month follow-up
  72. What happens to children with recent-onset tics, and why?
  73. Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease
  74. 2.54 EXPLORING BEHAVIORAL MARKERS PREDICTING ONE-YEAR TIC OUTCOME IN CHILDREN WITH RECENT-ONSET TICS
  75. Treating depression in epilepsy: a controlled trial
  76. The urge to blink in Tourette syndrome
  77. Tourette syndrome research highlights from 2018
  78. Atypical Functional Connectivity In Tourette Syndrome differs between Children and Adults
  79. Tic Suppression in Children With Recent-Onset Tics Predicts 1-Year Tic Outcome
  80. In Provisional Tic Disorder, better tic suppression predicts better prognosis
  81. Provisional Tic Disorder is not so transient
  82. Correction: Brain structure in pediatric Tourette syndrome
  83. Ziprasidone may have a role in treating psychosis in Parkinsonian disease
  84. The urge to blink in Tourette syndrome
  85. How to switch to pimavanserin from an older antipsychotic for psychosis in Parkinson's disease
  86. Atypical Functional Connectivity in Tourette Syndrome Differs Between Children and Adults
  87. Transient tics aren't: Outcome of recent-onset tic disorder at one year
  88. Testing a new (D1) dopamine blocking strategy to treat Tourette syndrome in children
  89. TicTrainer software
  90. Research on tic disorders from 2017
  91. Effects of DBS in dorsal vs. ventral STN
  92. Who can suppress tics best?
  93. Tourette Syndrome
  94. TicTimer software for measuring tic suppression
  95. TicTrainer web software for tic suppression training
  96. Tourette syndrome research highlights from 2016
  97. Patterns and predictors of tic suppressibility in youth with tic disorders
  98. 4.36 A Randomized, Double-Blind, Placebo-Controlled Study of the D1 Receptor Antagonist Ecopipam for Children and Adolescents With Tourette's Disorder
  99. TicTimer: software for measuring tic suppression
  100. Tourette syndrome research highlights from 2016
  101. Mapping movement, mood, motivation, and mentation in the subthalamic nucleus
  102. A Case of Apparent Upper-Body Freezing in Parkinsonism while Using a Wheelchair
  103. What creates the urge to tic in Tourette syndrome?
  104. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia
  105. Brain structure in pediatric Tourette syndrome
  106. VISIT-TS: A multimedia tool for population studies on tic disorders
  107. A picture is worth 1000 words: a new tool for Tourette studies
  108. Tourette syndrome research highlights 2015
  109. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status
  110. Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D 2 Receptor Binding and Age in Obesity
  111. Brain structure in pediatric Tourette syndrome
  112. When do tics turn into Tourette syndrome?
  113. Return of QuanDyn(TM)
  114. Designing MRI studies of children with neuropsychiatric disorders
  115. Machine learning "diagnosis" of Tourette syndrome by resting brain activity
  116. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  117. Safety of i.v. L-DOPA
  118. Automated training to hold still
  119. A review session can raise medical student scores on the psychiatry shelf exam
  120. Impact of a structured review session on medical student psychiatry subject examination performance
  121. Stand up for i.v. levodopa!
  122. Brain imaging in Tourette's, 2014-2015
  123. Safety of i.v. L-DOPA (preprint)
  124. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  125. Tourette Syndrome research highlights 2014
  126. Brain dopamine pathways influence emotional eating
  127. Rapid quantitative pharmacodynamic imaging with Bayesian estimation
  128. Whole-brain blood flow correction in ASL
  129. Tourette Syndrome research highlights 2014
  130. Kids can suppress tics early on--if the price is right
  131. Levodopa effects on [11C]raclopride binding in the resting human brain
  132. Tics
  133. Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI
  134. F1000Research: Tics welcomes you to 21st century biomedical publishing
  135. Intro to special issue on Tourette syndrome
  136. Current anxiety disorder affects mood response to STN DBS in PD
  137. A revised method for measuring distraction by tactile stimulation
  138. Anatomical location in STN matters for DBS in Parkinson's
  139. Insulin, dopamine D2 receptors, and monetary reward discounting: A common pathway for food and drug addiction
  140. Developmental Changes in the Organization of Functional Connections between the Basal Ganglia and Cerebral Cortex
  141. Spatial Reorganization of Putaminal Dopamine D2-Like Receptors in Cranial and Hand Dystonia
  142. Levodopa-stimulated dopamine release in Tourette syndrome
  143. A within-subject comparison of seizure duration with etomidate and methohexital in electroconvulsive therapy
  144. Prolactin and fMRI response to SKF38393 in the baboon
  145. Automatic size and shape measurements of deep brain structures in Tourette syndrome
  146. Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle
  147. Towards objectively quantifying sensory hypersensitivity: a pilot study of the “Ariana effect”
  148. Olanzapine for psychosis in Parkinson disease
  149. Neurobiology and Functional Anatomy of Tic Disorders
  150. A comparison of D2 receptor specific binding in obese and normal‐weight individuals using PET with (N‐[11C]methyl)benperidol
  151. NMB PET outside the striatum
  152. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
  153. Mood Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
  154. Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
  155. A New (Old) Treatment Option for Depression in Parkinson's Disease
  156. Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours
  157. Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (TSfMRI)
  158. A Perfusion MRI Study of Emotional Valence and Arousal in Parkinson’s Disease
  159. Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
  160. Tics
  161. Deep brain stimulation for Tourette syndrome
  162. Hippocampal Volumes in Youth With Type 1 Diabetes
  163. Neuroimaging in Baboons
  164. Cerebral Mitochondrial Metabolism in Early Parkinson's Disease
  165. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
  166. Psychiatric screening for DBS
  167. The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association
  168. Regional Brain Volume Differences Associated With Hyperglycemia and Severe Hypoglycemia in Youth With Type 1 Diabetes
  169. Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome
  170. Intravenous levodopa administration in humans based on a two-compartment kinetic model
  171. The Value of Quantitative Electroencephalography in Clinical Psychiatry: A Report by the Committee on Research of the American Neuropsychiatric Association
  172. Repetitive and impulsive behaviors in treated Parkinson disease
  173. II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance
  174. Sex, Lies, and Neuroimaging
  175. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
  176. Brain Stimulation in Psychiatric Treatment
  177. Blood Flow Imaging of the Brain: 50 Years Experience
  178. Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
  179. Pathophysiology of parkinsonism due to hydrocephalus
  180. Dopaminergic modulation of response inhibition: an fMRI study
  181. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study
  182. Atlas Template Images for Nonhuman Primate Neuroimaging: Baboon and Macaque
  183. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET)
  184. Rapid intravenous loading of levodopa for human research: clinical results
  185. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease
  186. A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
  187. Psychiatric Neuroimaging Research
  188. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  189. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  190. Template Images for Nonhuman Primate Neuroimaging: 2. Macaque
  191. Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
  192. Dopa-Induced Blood Flow Responses in Nonhuman Primates
  193. Response to levodopa challenge in Tourette syndrome
  194. Neuropsychiatry of movement disorders
  195. On the efficiency of stereologic volumetry as commonly implemented for three-dimensional digital images
  196. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm
  197. Altered thalamic response to levodopa in Parkinson’s patients with dopa-induced dyskinesias
  198. Putamen volume in idiopathic focal dystonia
  199. Preventing contractures in NMS and dystonia
  200. MPTP induces dystonia and parkinsonism
  201. Baboon Basal Ganglia Stereotaxy Using Internal MRI Landmarks: Validation and Application to PET Imaging
  202. Personality disorder scores improve with effective pharmacotherapy of depression
  203. Stereological MRI volumetry of the frontal lobe
  204. A Metric for Testing the Accuracy of Cross-Modality Image Registration: Validation and Application
  205. The Dexamethasone Suppression Test for Diagnosing Depression in Stroke Patients
  206. Anosognosia for Depressive Signs
  207. Diagnosing Depression After Stroke
  208. Platelet Binding Characteristics Distinguish Placebo Responders from Nonresponders in Depression
  209. MRI volumetry of prefrontal cortex
  210. Hippocampal MR volumetry
  211. Severe Imipramine-Induced Myoclonus in a Patient with Psychotic Bipolar Depression, Catatonia, and Schizencephaly
  212. Subcortical brain anatomy in anorexia and bulimia
  213. Faculty of 1000 evaluation for Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
  214. TicTimer software for measuring tic suppression
  215. “But my department chair wants big-name journals”: Gentle steps to open publishing
  216. Software for web-based tic suppression training
  217. Tics
  218. Treatment of Parkinson’s disease psychosis
  219. Tourette syndrome research highlights from 2016
  220. BillCorrectly: A software tool to help psychiatrists bill E&M codes appropriately
  221. Suggestions for new NIH grant applicants